Lista de obras - Ana Cecilia Rodríguez - Dominio Público Uruguay

A Comparison of Human Papillomavirus Genotype-Specific DNA and E6/E7 mRNA Detection to Identify Anal Precancer among HIV-Infected Men Who Have Sex with Men ⬇️

artículo científico publicado el 15 de noviembre de 2012

A candidate gene approach to searching for low-penetrance breast and prostate cancer genes

article

A competitive serological assay shows naturally acquired immunity to human papillomavirus infections in the Guanacaste Natural History Study

artículo científico publicado en 2011

A large, population-based study of age-related associations between vaginal pH and human papillomavirus infection

artículo científico publicado en 2012

A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia

artículo científico publicado en 2010

A population-based study of vaginal human papillomavirus infection in hysterectomized women

artículo científico publicado en 2004

A prospective study of absolute risk and determinants of human papillomavirus incidence among young women in Costa Rica ⬇️

artículo científico publicado el 8 de julio de 2013

A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica

artículo científico publicado en 2005

A study of the impact of adding HPV types to cervical cancer screening and triage tests

scientific article published on 01 January 2005

Age-related changes of the cervix influence human papillomavirus type distribution

artículo científico publicado en 2006

Alterations of T-cell surface markers in older women with persistent human papillomavirus infection

artículo científico publicado en 2011

An evaluation by midwives and gynecologists of treatability of cervical lesions by cryotherapy among human papillomavirus-positive women

artículo científico publicado en 2009

An updated natural history model of cervical cancer: derivation of model parameters

artículo científico publicado en 2014

Behavioral/Lifestyle and Immunologic Factors Associated with HPV Infection among Women Older Than 45 Years ⬇️

artículo científico publicado el 15 de octubre de 2010

CIN2 is a much less reproducible and less valid diagnosis than CIN3: results from a histological review of population-based cervical samples

artículo científico publicado en 2007

Chlamydia trachomatis and risk of prevalent and incident cervical premalignancy in a population-based cohort

artículo científico publicado en 2010

Clustering of multiple human papillomavirus infections in women from a population-based study in Guanacaste, Costa Rica

artículo científico publicado en 2011

Common genetic variants and risk for HPV persistence and progression to cervical cancer

artículo científico publicado en 2010

Common genetic variation in TP53 and risk of human papillomavirus persistence and progression to CIN3/cancer revisited ⬇️

artículo científico publicado en 2009

Common variants in immune and DNA repair genes and risk for human papillomavirus persistence and progression to cervical cancer

artículo científico publicado en 2009

Comparison of antibody responses to human papillomavirus vaccination as measured by three assays

scientific article published on 13 January 2014

Comparison of the SPF10-LiPA system to the Hybrid Capture 2 Assay for detection of carcinogenic human papillomavirus genotypes among 5,683 young women in Guanacaste, Costa Rica

artículo científico publicado en 2007

Comparison of two PCR-based human papillomavirus genotyping methods

artículo científico publicado en 2008

Cross-protection of the Bivalent Human Papillomavirus (HPV) Vaccine Against Variants of Genetically Related High-Risk HPV Infections.

artículo científico publicado en 2015

Cross-protective vaccine efficacy of the bivalent HPV vaccine against HPV31 is associated with humoral immune responses: results from the Costa Rica Vaccine Trial

artículo científico publicado en 2013

Determinants of seropositivity among HPV-16/18 DNA positive young women

artículo científico publicado en 2010

Durable antibody responses following one dose of the bivalent human papillomavirus L1 virus-like particle vaccine in the Costa Rica Vaccine Trial

artículo científico publicado en 2013

Effect of bivalent human papillomavirus vaccination on pregnancy outcomes: long term observational follow-up in the Costa Rica HPV Vaccine Trial

artículo científico publicado en 2015

Effect of different human papillomavirus serological and DNA criteria on vaccine efficacy estimates

artículo científico publicado en 2014

Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial ⬇️

artículo científico publicado el 22 de agosto de 2011

Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA Trials

artículo científico publicado en 2015

Elevated methylation of HPV16 DNA is associated with the development of high grade cervical intraepithelial neoplasia

artículo científico publicado en 2012

Elevated systemic levels of inflammatory cytokines in older women with persistent cervical human papillomavirus infection

artículo científico publicado en 2010

Epidemiological Study of Anti-HPV16/18 Seropositivity and Subsequent Risk of HPV16 and -18 Infections ⬇️

artículo científico publicado el 13 de octubre de 2010

Evaluation of Type Replacement Following HPV16/18 Vaccination: Pooled Analysis of Two Randomized Trials

artículo científico publicado en 2017

Evaluation of a novel PCR-based assay for detection and identification of Chlamydia trachomatis serovars in cervical specimens

artículo científico publicado en 2007

Evaluation of systemic and mucosal anti-HPV16 and anti-HPV18 antibody responses from vaccinated women

artículo científico publicado en 2008

Evaluation of the FTA carrier device for human papillomavirus testing in developing countries

artículo científico publicado en 2012

Evaluation of the Polyclonal ELISA HPV Serology Assay as a Biomarker for Human Papillomavirus Exposure ⬇️

artículo científico publicado el 1 de octubre de 2011

Evaluation of two types of sponges used to collect cervical secretions and assessment of antibody extraction protocols for recovery of neutralizing anti-human papillomavirus type 16 antibodies

artículo científico publicado en 2007

Factors associated with fluctuations in IgA and IgG levels at the cervix during the menstrual cycle

artículo científico publicado en 2009

Genome-wide association study of prostate cancer identifies a second risk locus at 8q24

artículo científico publicado en 2007

Glutathione S-transferase L1 multiplex serology as a measure of cumulative infection with human papillomavirus

artículo científico publicado en 2014

HPV16 seropositivity and subsequent HPV16 infection risk in a naturally infected population: comparison of serological assays

artículo científico publicado en 2013

Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci

artículo científico publicado en 2005

High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease

artículo científico publicado en 2007

Human Papillomavirus Infection with Multiple Types: Pattern of Coinfection and Risk of Cervical Disease ⬇️

artículo científico publicado el 1 de abril de 2011

Human papillomavirus and cervical cancer

artículo científico publicado en 2007

Human papillomavirus types by age in cervical cancer precursors: predominance of human papillomavirus 16 in young women

artículo científico publicado en 2009

Immunogenicity assessment of HPV16/18 vaccine using the glutathione S-transferase L1 multiplex serology assay

artículo científico publicado en 2014

Impact of Human Papillomavirus Vaccination on Cervical Cytology Screening, Colposcopy, and Treatment ⬇️

artículo científico publicado el 10 de julio de 2013

Impact of human papillomavirus (HPV) 16 and 18 vaccination on prevalent infections and rates of cervical lesions after excisional treatment

artículo científico publicado en 2016

Increased plasma levels of adipokines and inflammatory markers in older women with persistent HPV infection

artículo científico publicado en 2010

Invited commentary: multiple human papillomavirus infections and type replacement-anticipating the future after human papillomavirus vaccination

artículo científico publicado en 2014

Lack of heterogeneity of HPV16 E7 sequence compared with HPV31 and HPV73 may be related to its unique carcinogenic properties

artículo científico publicado en 2010

Long-Term Persistence of Prevalently Detected Human Papillomavirus Infections in the Absence of Detectable Cervical Precancer and Cancer ⬇️

artículo científico publicado el 15 de marzo de 2011

Longitudinal Analysis of Carcinogenic Human Papillomavirus Infection and Associated Cytologic Abnormalities in the Guanacaste Natural History Study: Looking Ahead to Cotesting ⬇️

artículo científico publicado el 5 de diciembre de 2011

Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection

artículo científico publicado en 2010

Long‐term risk of recurrent cervical human papillomavirus infection and precancer and cancer following excisional treatment ⬇️

artículo científico publicado el 30 de agosto de 2011

Low risk of type-specific carcinogenic HPV re-appearance with subsequent cervical intraepithelial neoplasia grade 2/3.

artículo científico publicado en 2012

Methylation of human papillomavirus type 16 genome and risk of cervical precancer in a Costa Rican population

artículo científico publicado en 2012

Multisite HPV16/18 Vaccine Efficacy Against Cervical, Anal, and Oral HPV Infection.

artículo científico publicado en 2015

Neither one-time negative screening tests nor negative colposcopy provides absolute reassurance against cervical cancer

artículo científico publicado en 2009

Oral Immunoglobulin Levels are Not a Good Surrogate for Cervical Immunoglobulin Levels ⬇️

artículo científico publicado el 25 de junio de 2012

PCR testing of pooled longitudinally collected cervical specimens of women to increase the efficiency of studying human papillomavirus infection.

artículo científico publicado en 2005

Performance of self-collected cervical samples in screening for future precancer using human papillomavirus DNA testing

artículo científico publicado en 2014

Persistence of Concurrent Infections with Multiple Human Papillomavirus Types: A Population-based Cohort Study ⬇️

artículo científico publicado el 21 de enero de 2011

Preparing digitized cervigrams for colposcopy research and education: determination of optimal resolution and compression parameters

artículo científico publicado en 2006

Prevalence of and Risk Factors for Anal Human Papillomavirus Infection Among Young Healthy Women in Costa Rica ⬇️

artículo científico publicado el 30 de julio de 2012

Prevalence of and Risk Factors for Oral Human Papillomavirus Among Young Women in Costa Rica ⬇️

artículo científico publicado el 6 de septiembre de 2013

Prevention of Persistent Human Papillomavirus Infection by an HPV16/18 Vaccine: A Community-Based Randomized Clinical Trial in Guanacaste, Costa Rica ⬇️

artículo científico publicado el 9 de septiembre de 2011

Proof-of-principle evaluation of the efficacy of fewer than three doses of a bivalent HPV16/18 vaccine

artículo científico publicado en 2011

Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections

artículo científico publicado en 2008

Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica

artículo científico publicado en 2008

Rationale and design of a long term follow-up study of women who did and did not receive HPV 16/18 vaccination in Guanacaste, Costa Rica

artículo científico publicado en 2015

Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica

artículo científico publicado en 2013

Reduced prevalence of vulvar HPV16/18 infection among women who received the HPV16/18 bivalent vaccine: a nested analysis within the Costa Rica Vaccine Trial

artículo científico publicado en 2014

Relationships of human papillomavirus type, qualitative viral load, and age with cytologic abnormality

artículo científico publicado en 2006

Response to "Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccines" by Verstraeten et al.

artículo científico publicado en 2009

Risk of miscarriage with bivalent vaccine against human papillomavirus (HPV) types 16 and 18: pooled analysis of two randomised controlled trials

artículo científico publicado en 2010

Seroprevalence and correlates of human papillomavirus 16/18 seropositivity among young women in Costa Rica

artículo científico publicado en 2010

Single nucleotide polymorphisms in the PRDX3 and RPS19 and risk of HPV persistence and cervical precancer/cancer

artículo científico publicado en 2012

Switch from cytology-based to human papillomavirus test-based cervical screening: implications for colposcopy

artículo científico publicado en 2011

The carcinogenicity of human papillomavirus types reflects viral evolution

artículo científico publicado en 2005

The cervical microbiome over 7 years and a comparison of methodologies for its characterization

artículo científico publicado en 2012

The natural history of human papillomavirus infection and cervical intraepithelial neoplasia among young women in the Guanacaste cohort shortly after initiation of sexual life

artículo científico publicado en 2007

Lista de obras de Ana Cecilia Rodríguez

A Comparison of Human Papillomavirus Genotype-Specific DNA and E6/E7 mRNA Detection to Identify Anal Precancer among HIV-Infected Men Who Have Sex with Men ⬇️

A candidate gene approach to searching for low-penetrance breast and prostate cancer genes

A competitive serological assay shows naturally acquired immunity to human papillomavirus infections in the Guanacaste Natural History Study

A large, population-based study of age-related associations between vaginal pH and human papillomavirus infection

A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia

A population-based study of vaginal human papillomavirus infection in hysterectomized women

A prospective study of absolute risk and determinants of human papillomavirus incidence among young women in Costa Rica ⬇️

A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica

A study of the impact of adding HPV types to cervical cancer screening and triage tests

Age-related changes of the cervix influence human papillomavirus type distribution

Alterations of T-cell surface markers in older women with persistent human papillomavirus infection

An evaluation by midwives and gynecologists of treatability of cervical lesions by cryotherapy among human papillomavirus-positive women

An updated natural history model of cervical cancer: derivation of model parameters

Behavioral/Lifestyle and Immunologic Factors Associated with HPV Infection among Women Older Than 45 Years ⬇️

CIN2 is a much less reproducible and less valid diagnosis than CIN3: results from a histological review of population-based cervical samples

Chlamydia trachomatis and risk of prevalent and incident cervical premalignancy in a population-based cohort

Clustering of multiple human papillomavirus infections in women from a population-based study in Guanacaste, Costa Rica

Common genetic variants and risk for HPV persistence and progression to cervical cancer

Common genetic variation in TP53 and risk of human papillomavirus persistence and progression to CIN3/cancer revisited ⬇️

Common variants in immune and DNA repair genes and risk for human papillomavirus persistence and progression to cervical cancer

Comparison of antibody responses to human papillomavirus vaccination as measured by three assays

Comparison of the SPF10-LiPA system to the Hybrid Capture 2 Assay for detection of carcinogenic human papillomavirus genotypes among 5,683 young women in Guanacaste, Costa Rica

Comparison of two PCR-based human papillomavirus genotyping methods

Cross-protection of the Bivalent Human Papillomavirus (HPV) Vaccine Against Variants of Genetically Related High-Risk HPV Infections.

Cross-protective vaccine efficacy of the bivalent HPV vaccine against HPV31 is associated with humoral immune responses: results from the Costa Rica Vaccine Trial

Determinants of seropositivity among HPV-16/18 DNA positive young women

Durable antibody responses following one dose of the bivalent human papillomavirus L1 virus-like particle vaccine in the Costa Rica Vaccine Trial

Effect of bivalent human papillomavirus vaccination on pregnancy outcomes: long term observational follow-up in the Costa Rica HPV Vaccine Trial

Effect of different human papillomavirus serological and DNA criteria on vaccine efficacy estimates

Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial ⬇️

Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA Trials

Elevated methylation of HPV16 DNA is associated with the development of high grade cervical intraepithelial neoplasia

Elevated systemic levels of inflammatory cytokines in older women with persistent cervical human papillomavirus infection

Epidemiological Study of Anti-HPV16/18 Seropositivity and Subsequent Risk of HPV16 and -18 Infections ⬇️

Evaluation of Type Replacement Following HPV16/18 Vaccination: Pooled Analysis of Two Randomized Trials

Evaluation of a novel PCR-based assay for detection and identification of Chlamydia trachomatis serovars in cervical specimens

Evaluation of systemic and mucosal anti-HPV16 and anti-HPV18 antibody responses from vaccinated women

Evaluation of the FTA carrier device for human papillomavirus testing in developing countries

Evaluation of the Polyclonal ELISA HPV Serology Assay as a Biomarker for Human Papillomavirus Exposure ⬇️

Evaluation of two types of sponges used to collect cervical secretions and assessment of antibody extraction protocols for recovery of neutralizing anti-human papillomavirus type 16 antibodies

Factors associated with fluctuations in IgA and IgG levels at the cervix during the menstrual cycle

Genome-wide association study of prostate cancer identifies a second risk locus at 8q24

Glutathione S-transferase L1 multiplex serology as a measure of cumulative infection with human papillomavirus

HPV16 seropositivity and subsequent HPV16 infection risk in a naturally infected population: comparison of serological assays

Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci

High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease

Human Papillomavirus Infection with Multiple Types: Pattern of Coinfection and Risk of Cervical Disease ⬇️

Human papillomavirus and cervical cancer

Human papillomavirus types by age in cervical cancer precursors: predominance of human papillomavirus 16 in young women

Immunogenicity assessment of HPV16/18 vaccine using the glutathione S-transferase L1 multiplex serology assay

Impact of Human Papillomavirus Vaccination on Cervical Cytology Screening, Colposcopy, and Treatment ⬇️

Impact of human papillomavirus (HPV) 16 and 18 vaccination on prevalent infections and rates of cervical lesions after excisional treatment

Increased plasma levels of adipokines and inflammatory markers in older women with persistent HPV infection

Invited commentary: multiple human papillomavirus infections and type replacement-anticipating the future after human papillomavirus vaccination

Lack of heterogeneity of HPV16 E7 sequence compared with HPV31 and HPV73 may be related to its unique carcinogenic properties

Long-Term Persistence of Prevalently Detected Human Papillomavirus Infections in the Absence of Detectable Cervical Precancer and Cancer ⬇️

Longitudinal Analysis of Carcinogenic Human Papillomavirus Infection and Associated Cytologic Abnormalities in the Guanacaste Natural History Study: Looking Ahead to Cotesting ⬇️

Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection

Long‐term risk of recurrent cervical human papillomavirus infection and precancer and cancer following excisional treatment ⬇️

Low risk of type-specific carcinogenic HPV re-appearance with subsequent cervical intraepithelial neoplasia grade 2/3.

Methylation of human papillomavirus type 16 genome and risk of cervical precancer in a Costa Rican population

Multisite HPV16/18 Vaccine Efficacy Against Cervical, Anal, and Oral HPV Infection.

Neither one-time negative screening tests nor negative colposcopy provides absolute reassurance against cervical cancer

Oral Immunoglobulin Levels are Not a Good Surrogate for Cervical Immunoglobulin Levels ⬇️

PCR testing of pooled longitudinally collected cervical specimens of women to increase the efficiency of studying human papillomavirus infection.

Performance of self-collected cervical samples in screening for future precancer using human papillomavirus DNA testing

Persistence of Concurrent Infections with Multiple Human Papillomavirus Types: A Population-based Cohort Study ⬇️

Preparing digitized cervigrams for colposcopy research and education: determination of optimal resolution and compression parameters

Prevalence of and Risk Factors for Anal Human Papillomavirus Infection Among Young Healthy Women in Costa Rica ⬇️

Prevalence of and Risk Factors for Oral Human Papillomavirus Among Young Women in Costa Rica ⬇️

Prevention of Persistent Human Papillomavirus Infection by an HPV16/18 Vaccine: A Community-Based Randomized Clinical Trial in Guanacaste, Costa Rica ⬇️

Proof-of-principle evaluation of the efficacy of fewer than three doses of a bivalent HPV16/18 vaccine

Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections

Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica

Rationale and design of a long term follow-up study of women who did and did not receive HPV 16/18 vaccination in Guanacaste, Costa Rica

Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica

Reduced prevalence of vulvar HPV16/18 infection among women who received the HPV16/18 bivalent vaccine: a nested analysis within the Costa Rica Vaccine Trial

Relationships of human papillomavirus type, qualitative viral load, and age with cytologic abnormality

Response to "Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccines" by Verstraeten et al.